导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -14.31% | 907/1050 |
| 近一周 | -3.34% | 866/1104 |
| 近一月 | -3.44% | 460/1102 |
| 近一季 | 0.22% | 304/1092 |
| 近半年 | -11.23% | 814/1070 |
| 近一年 | -21.17% | 930/1018 |
| 近两年 | 2.80% | 878/926 |
| 近三年 | -31.49% | 812/833 |
| 成立以来 | 63.52% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-5.95% 858/1070 |
-14.74% 1014/1101 |
- - |
- - |
| 2025 | -5.11% 946/1065 |
0.76% 739/1014 |
-4.35% 942/1038 |
3.17% 963/1050 |
-4.56% 693/1065 |
| 2024 | -4.33% 682/1011 |
0.70% 279/960 |
-12.18% 911/983 |
14.58% 260/991 |
-5.58% 701/1011 |
| 2023 | -20.88% 690/952 |
2.49% 475/880 |
-13.67% 845/895 |
-2.15% 159/915 |
-8.61% 795/952 |
| 2022 | -11.54% 105/867 |
-21.57% 612/773 |
22.64% 8/806 |
-11.02% 303/845 |
3.36% 268/867 |
| 2021 | 6.02% 289/740 |
-6.20% 390/580 |
16.24% 218/659 |
-10.65% 525/704 |
8.82% 103/740 |
| 2020 | 96.48% 41/554 |
0.92% 137/419 |
26.62% 169/466 |
21.91% 39/517 |
26.12% 59/554 |
| 2019 | 56.63% 98/410 |
36.38% 116/1146 |
10.38% 13/1228 |
-0.59% 347/390 |
4.68% 347/410 |
| 2018 | -19.88% 77/349 |
- - |
11.40% 3/990 |
-6.90% 561/1000 |
-16.26% 922/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8316 | 54.00% |
| 招商前沿医疗保健股票C | 0.7978 | 53.69% |
| 招商医药健康产业股票 | 2.5730 | 48.73% |
| 嘉实医疗保健股票 | 2.5780 | 39.05% |
| 广发医药精选股票A | 1.3132 | 38.48% |
| 广发医药精选股票C | 1.2923 | 38.32% |
| 前海开源公共卫生股票A | 0.4690 | 37.42% |
| 前海开源公共卫生股票C | 0.4590 | 37.30% |
| 交银医药创新股票C | 3.0594 | 35.86% |
| 交银医药创新股票A | 2.8810 | 32.85% |
| 银华食品饮料量化股票发起式A VS. 东吴新产业精选股票A(580008) |